Latest news with #AaronDumasJr
Associated Press
04-07-2025
- Business
- Associated Press
Shareholder Alert: Robbins LLP Informs Investors of the Apple, Inc. Class Action Lawsuit
SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or acquired Apple, Inc. (NASDAQ: AAPL) securities between June 10, 2024 and June 9, 2025. Apple is a multinational technology company that engages primarily in the business of smart-device and computer design and manufacturing, entertainment and artificial intelligence ('AI'). For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations That Apple, Inc. (AAPL) Misled Investors Regarding the Availability of Updates to its AI-Based Siri Feature According to the complaint, in June 2024, Apple announced advanced AI-based Siri features as the primary reason for customers to purchase the iPhone 16. Plaintiff contends, however, that during the class period, defendants failed to disclose that: (i) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (ii) accordingly, it was highly unlikely that these features would be available for the iPhone 16; (iii) the lack of such advanced AI-based features would hurt iPhone 16 sales; and (iv) as a result, Apple's business and/or financial prospects were overstated. When the truth was revealed, Apple's stock price fell, harming investors. What Now: You may be eligible to participate in the class action against Apple, Inc. Shareholders who want to serve as lead plaintiff for the class are required to submit their motions to the court by August 19, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Apple, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome.
Associated Press
01-07-2025
- Business
- Associated Press
RCAT Stock News: Robbins LLP Reminds Red Cat Holdings, Inc. Investors of the Pending Lead Plaintiff Deadline in the RCAT Class Action – Contact Robbins LLP Before July 22 for Information
SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Red Cat Holdings, Inc. (NASDAQ: RCAT) securities between March 18, 2022 and January 15, 2025. Red Cat, together with its subsidiaries, provides various products, services, and solutions to the U.S. drone industry. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Red Cat Holdings (RCAT) Misled Investors Regarding its Production Capacity According to the complaint, during the class period, defendants failed to disclose that: (i) the Salt Lake City Facility's production capacity, and defendants' progress in developing the same, was overstated; and (ii) the overall value of the SRR (U.S. Army's Short Range Reconnaissance Program of Record) Contract was overstated. The complaint alleges that on January 16, 2025, Kerrisdale Capital published a report alleging, inter alia, that defendants had overstated the value of the SRR Contract, which Kerrisdale found was only worth approximately $20 million to $25 million based on U.S. Army budget documents. The Kerrisdale Report also alleged that defendants had been misleading investors about the Salt Lake City Facility's production capacity for years, while also raising concerns about the timing of executive departures and insider transactions that took place shortly after Red Cat announced it had won the SRR Contract. On this news, Red Cat's stock price fell $2.35 per share, or 21.54%, over the following two trading sessions, to close at $8.56 per share on January 17, 2025. What Now: You may be eligible to participate in the class action against Red Cat Holdings, Inc. Shareholders who want to serve as lead plaintiff for the class have until July 22, 2025, to seek lead plaintiff status with the court. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Red Cat Holdings, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome.
Associated Press
14-06-2025
- Business
- Associated Press
VSTS Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Vestis Corporation
SAN DIEGO, June 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Vestis Corporation (NYSE:VSTS) securities between May 2, 2024 and May 6, 2025. Vestis is a North American company that provides uniform rentals and workplace supplies across the U.S. and Canada. For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Vestis Corporation (VSTS) Misled Investors regarding Customer Growth According to the complaint, defendants failed to disclose to investors that Vestis would be unable to execute on planned strategic initiatives to drive purported improvements to the customer experience and its onboarding efforts in order to drive new customer growth, increased customer retention, and increased revenue from existing customers. The complaint alleges that these statements caused stockholders to purchase Vestis' securities at artificially inflated prices. According to the complaint, on May 7, 2025, Vestis announced its financial results for the second quarter of fiscal 2025, withdrew its revenue and growth guidance for the full fiscal year 2025, and provided guidance for the third quarter of fiscal 2025 that fell significantly below market expectations. The Company attributed its poor results partially to 'lost business in excess of new business,' but primarily on 'lower adds over stops, which is how we describe volume changes with our existing customers.' The Company attributed its decision to pull full-year guidance and provide disappointing third quarter targets to the 'increasingly uncertain macro environment.' On this news, the price of Vestis' common stock fell from a closing market price of $8.71 per share on May 6, 2025, to $5.44 per share on May 7, 2025, a decline of about 37.54% in the span of just a single day. What Now: You may be eligible to participate in the class action against Vestis Corporation. Shareholders who want to serve as lead plaintiff for the class must file a motion for lead plaintiff by August 8, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Vestis Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome.
Associated Press
14-05-2025
- Business
- Associated Press
ELV Shareholder Alert: Robbins LLP Informs Investors of the Elevance Health, Inc. Class Action Lawsuit
SAN DIEGO, CA - May 13, 2025 ( NEWMEDIAWIRE ) - Robbins LLP informs stockholders that a class action was filed on behalf of all purchasers of Elevance Health, Inc. (NYSE: ELV) common stock between April 18, 2024 and October 16, 2024. Elevance is a healthcare company that, among other things, provides health insurance plans to a variety of markets. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Elevance Health, Inc. (ELV) Failed to Disclose the Impact Medicaid Redetermination Would Have on its Business Prospects According to the complaint, during the class period, defendants represented to investors that they were closely monitoring cost trends associated with the Medicaid redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. While Defendants acknowledged that Medicaid expenses were rising, they repeatedly assured investors that this was adequately reflected in the Company's guidance for the year. Defendants further reassured investors that 'we're intentionally remaining thoughtful and prudent in our outlook,' and that, while the Company was seeing an acuity mix shift in the Medicaid business, it was 'nothing outside of the bounds of what we've expected and guided for.' In truth, the redeterminations were causing the acuity and utilization of Elevance's Medicaid members to rise significantly, as sicker patients with higher acuity tended to remain on Medicaid after redetermination, leading to higher per-patient costs. This shift was occurring to a degree that was not reflected in Elevance's rate negotiations with the states or in its financial guidance for 2024. On July 17, 2024, the Company revealed that it was now 'expecting second-half utilization to increase in Medicaid' and that it was 'seeing signs of increased utilization across the broader Medicaid population, including in outpatient home health, radiology, durable medical equipment, as well as some elective procedures.' In response to these disclosures, the price of Elevance common stock declined by $32.21 per share, or 5.8%, from a closing price of $553.14 on July 16, 2024, to a closing price of $520.93 on July 17, 2024. What Now: You may be eligible to participate in the class action against Elevance Health, Inc. Shareholders who want to serve as lead plaintiff for the class are required to file their papers with the court by July 11, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Elevance Health, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. Contact: Aaron Dumas, Jr. Robbins LLP 5060 Shoreham Pl., Ste. 300 San Diego, CA 92122 [email protected] (800) 350-6003 View the original release on
